[Hollysys Automation Technologies Appoints New Board Chairman Beijing, China – May 31, 2010 – Hollysys Automation Technologies, Ltd. (NASDAQ: HOLI) Madam Li Qiao, who had served as Chairwoman since 2007, resigned from the Board of Directors in connection with the reduction, effective May 26, 2010, together with three other non-executive directors: Messrs. Kerry S. Propper, Leonard Hafetz, and Kiam Fee]
[WuXi PharmaTech (Cayman) Inc. Form 6-K TABLE OF CONTENTS Page 3 4 2 WuXi PharmaTech (Cayman) Inc.]
[Hollysys Automation Technologies Appoints New Board Chairman Beijing, China – May 31, 2010 – Hollysys Automation Technologies, Ltd. (NASDAQ: HOLI) Madam Li Qiao, who had served as Chairwoman since 2007, resigned from the Board of Directors in connection with the reduction, effective May 26, 2010, together with three other non-executive directors: Messrs. Kerry S. Propper, Leonard Hafetz, and Kiam Fee]
[WuXi PharmaTech (Cayman) Inc. Form 6-K TABLE OF CONTENTS Page 3 4 2 WuXi PharmaTech (Cayman) Inc.]
[Concord Medical Announces First Quarter 2010 Financial Results 1 BEIJING, May 27, 2010 Concord Medical Services Holdings Limited (Concord Medical or the Company) (NYSE: CCM), the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited financial results for the first quarter ended March 31, 2010 First Quarter Fiscal 2010 Highlights ] [FORM 6-K CONCORD MEDICAL SERVICES HOLDINGS LIMITED 18/F, Tower A, Global Trade Center þ o Form 20-F o o o þ Yes 82- N/A TABLE OF CONTENTS EX-99.1 TABLE OF CONTENTS 2 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Jianyu Yang Director, Chief Executive Officer and President 3 6-K 1 h04269e6vk.htm FORM 6-K]
[Form 6-K TABLE OF CONTENTS Page 3 4 2 WuXi PharmaTech (Cayman) Inc. Ge Li Chairman and CEO 3 ACQUISITION PROPOSEDYOUR VOTE IS VERY IMPORTANT Dear Shareholder: You are cordially invited to the upcoming special meeting of shareholders of Charles River to be held on [ in vivo [ [ []
[Concord Medical Announces First Quarter 2010 Financial Results 1 BEIJING, May 27, 2010 Concord Medical Services Holdings Limited (Concord Medical or the Company) (NYSE: CCM), the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited financial results for the first quarter ended March 31, 2010 First Quarter Fiscal 2010 Highlights ] [FORM 6-K CONCORD MEDICAL SERVICES HOLDINGS LIMITED 18/F, Tower A, Global Trade Center þ o Form 20-F o o o þ Yes 82- N/A TABLE OF CONTENTS EX-99.1 TABLE OF CONTENTS 2 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Jianyu Yang Director, Chief Executive Officer and President 3 6-K 1 h04269e6vk.htm FORM 6-K]
[Form 6-K TABLE OF CONTENTS Page 3 4 2 WuXi PharmaTech (Cayman) Inc. Ge Li Chairman and CEO 3 ACQUISITION PROPOSEDYOUR VOTE IS VERY IMPORTANT Dear Shareholder: You are cordially invited to the upcoming special meeting of shareholders of Charles River to be held on [ in vivo [ [ []
[CALCULATION OF REGISTRATION FEE TitleofEachClassofSecuritiestoBeRegistered AmounttoBe Registered ProposedMaximumgregateOffering (1) Price Amountof RegistrationFee (2) Shares ofmmon Stock, $.001 par value $ 28,750,000 $ 2,049.88 (3) (4) Underwritersmmon Stock Purchase Option 1 option $ 100 $ - Shares ofmmon Stock underlying Underwritersmmon Stock Purchase Option $ 781,250 $] [UNDERWRITINGREEMENT betweenYSTAR BIO-PHARMACEUTICALMPANY and RODMAN & RENSHAW, RepresentativeYSTAR BIO-PHARMACEUTICALMPANY UNDERWRITINGREEMENT New York, New York ___________ __, 2010 Rodman & Renshaw, th 1251 Avenue of the Americas, 20 New York, New York 10020 Ladies and Gentlemen:mpany Representative Underwriters Underwriter 1. Purchase andle of Securities.] [Form of Representatives Optionreement THE REGISTERED HOLDER OF THIS PURCHASE OPTION BY ITS ACCEPTANCE HEREOF,REES THAT IT WILL NOT SELL, TRANSFER ORSIGN THIS PURCHASE OPTION EXCEPT HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE OPTIONREES THAT IT WILL NOT SELL, TRANSFER,SIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE OPTION FOR A PERIOD OF ONE HUNDRED EIGHTYYS] [RICHARDSON & PATEL 10900 Wilshire Boulevard Suite 500 Los Angeles,lifornia 90024 Telephone (310) 208-1183 Facsimile (310) 208-1154 ___________________, 2010YSTAR BIO-PHARMACEUTICALMPANY Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xian Province, P.R. China Re:YSTAR BIO-PHARMACEUTICALMPANY Ladies and Gentlemen: Innnection with this opinion, we have examined originals orpies of the registration statement, the proceedings of] [Consent of Independent Registered Public Accounting Firm To the Board of Directorsystar Bio-Pharmaceuticalmpany Wensent to the use of our reportted March 31, 2010, with respect to thensolidated financial statements ofystar Bio-Pharmaceuticalmpany and Subsidiaries (thempany) of December 31, 2009 and 2008 and for the related statements ofome and othermprehensiveome, shareholders equity andsh flows for each of]
[Form 6-K TABLE OF CONTENTS Page 3 4 2]
